MIAN
AZN icon

Mariner Independent Advisor Network’s AstraZeneca AZN Stock Holding History

Mariner Independent Advisor Network’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9,247
Closed -$646K – 156
2018
Q1 		$646K Buy
+9,247
New +$641K 0.04% 264

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Mariner Independent Advisor Network's AZN Position: Q2 2018 in Review

Mariner Independent Advisor Network sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 9,247 shares — an estimated $646K sold.

Mariner Independent Advisor Network first reported a position in AZN in Q1 2018 and held it in 1 quarter. The position peaked at $646K in Q1 2018. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

  • Mariner Independent Advisor Network reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 9,247 AstraZeneca shares in Q2 2018, an estimated $646K.
  • Mariner Independent Advisor Network first reported a position in AstraZeneca in Q1 2018 and held it in 1 quarter.
  • Mariner Independent Advisor Network's AstraZeneca position peaked at $646K in Q1 2018.
  • 530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2018, filed 17 Sep 2018.